Decrease gap between two doses of Covishield to 8-16 weeks, suggests panel

The government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, based on the recommendations by NTAGI that provide guidance to the Union Health Ministry on the immunization

Published On 2022-03-21 07:30 GMT   |   Update On 2024-02-16 17:04 GMT
Advertisement

New Delhi: The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of COVID vaccine Covishield to 8 to 16 weeks in view of the ongoing Omicron pandemic, said a source on Sunday.

Presently, the second dose of Covishield is being administered 12-16 weeks after the first dose under the national vaccination drive. India's apex body on immunization now recommends this be curbed to ramp up the administration of the second dose of Covishield to the remaining population amid rising cases in European nations and some other countries.

Advertisement

Also Read:Covishield - Covaxin Combo Provides Greater Immunity says ICMR

The government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, based on the recommendations by NTAGI that provide guidance to the Union Health Ministry on the immunization.

However, India continues on the downward trend of new Covid cases. A total of 1,761 fresh COVID cases was recorded nationwide on Sunday which is the lowest in around 688 days. Following a continuous downward trend, India's active caseload has also declined to 26,240, constituting 0.06 percent of total positive cases. 

Medical Dialogues team had recently published that the COVID-19 vaccine administered for children aged between 12 and 14 years, Corbevax, was being sold to the government at Rs 145 per dose, said Biological E, which is the Hyderabad based manufacturer of the vaccine, whereas it will cost Rs 800 in the private market. As per a media report in the Economic Times, the vaccine would cost around Rs 800 without taxes in the private market, said Mahima Datla, managing director of Biological E at a press conference. However, it would cost around Rs 990 after GST and administering charges. 

Also Read:COVID vaccine effectiveness not up to the mark after 6 months without boosters

Tags:    
Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News